Laxatives Market - Forecast(2024 - 2030)

Report Code: HCR 0589 Report Format: PDF + Excel

Laxatives Market Overview

The global Laxatives market is estimated to grow at a CAGR of 5.76% during the forecast period 2019–2025. The market is projected to grow from $5,575.8mn in 2018 to $8,249.4Mn by 2025. Laxatives are medicines that help resolve constipation or empty the bowel of fecal matter. Some soften or loosen up the stool, while others increase how frequently the large colon contracts helping bowel movement. In some cases, it is used to flush bowel fecal matter for procedures or surgery involving the lower bowel.

Key Takeaways

  • In the coming years, growing interest in Laxatives is due to the application in Adults and Senior citizens.
  • Product launch was a key sustainability strategy adopted by the market players to ensure the growth of Laxatives market.
  • Europe region is estimated to record the fastest growth rate during the forecast period.

Drug Type - Segment Analysis

In 2018, Bulk – Forming segment dominated the Laxatives Market in terms of revenue. It is forecast to grow at a CAGR of 2.42% during the period under consideration. Bulking- forming agents absorb water and swell in the intestines to create a softer, bulky stool that is easy to pass. Psyllium, a bulk-forming drug is mostly prescribed by doctors to soothe bowel movement. Various Osmotic or stimulant laxatives are used for treating constipation. Osmotic laxatives attract water increases the flow of bowel in colon. And stimulant laxatives stimulate muscles to contract and help in bowel movement.

Route of Administration - Segment Analysis

In 2018, Oral drugs segment dominated the Laxatives Market in terms of revenue. Oral laxatives are medicines taken by mouth to encourage bowel movements to relieve constipation. Rectal laxatives are usually used for children in case of constipation.

Indication - Segment Analysis

The Chronic Constipation segment dominated the Laxatives market in 2018. Cases of constipation are quite common when people consume uncommon foods, contaminated food and others. Laxatives are also prescribed for patients with irritable bowel syndrome.Some disease conditions also tend to cause constipation such as in the case of diverticulosis. Also certain medications like calcium channel blockers or anticonvulsants are said to cause constipation.

Distribution - Segment Analysis

In 2018, Pharmacies segment dominated the market in terms of revenue. As laxatives are OTC medicines, it can be easily procured by any individual experiencing an upset stomach, aiding the growth of laxative market.

End User- Segment Analysis

Adults segment dominated the global Laxatives market in 2018. Increasing number of patients experiencing bowel disorders due to the unhealthy food habits results the growth of the laxatives market. Applications of laxative for senior citizens are also fast growing.

 Geography - Segment Analysis

In 2018, the North America region occupied 38% of the global Laxatives market in terms of revenue. According to the Centers of Diseases Control and Prevention (CDC), in U.S., 3Mn people were diagnosed with Inflammatory Bowel Disease Prevalence (IBD). The increasing awareness of the gastrointestinal diseases within the general population is an additional reason for the dominance of this region.

Drivers – Laxatives Market

·         Growth of geriatric population

The prevalence of bowel disorders increases in aging population. This is due to their body’s inability to digest food properly. The losing the elasticity of muscles and improper functioning leads to serious issues. These causes has led to the growing application of laxatives in senior citizens.

·         Unhealthy eating habits among public

 The current eating habits, sedentary lifestyle and other behaviors have led to increase the occurrences of improper bowel functioning. Due to the inactive lifestyle, food takes longer than usual to digest and in turn forms gastric diseases.

Challenges – Laxatives Market

·         Fear of side effects

Some people fear laxatives as they believe that laxatives leads to side effects on the long run. Thus, people shift from using laxatives to living a healthy lifestyle comprising of fibrous and healthy diets.

Market Landscape

Product Launches along is the key strategy of the players in the Laxatives industry. Laxatives top 10 companies include Abbott Laboratories, AstraZeneca, Bayer, Boehringer Ingelheim, Braintree Laboratories, GlaxoSmithKline, Procter & Gamble Company, Purdue Pharma, Sucampo Pharmaceuticals, Takeda Pharmaceutical Company.

Laxatives Industry Outlook:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Laxatives Market. The assessment includes the forecast, an overview of the competitive structure, the laxatives market size, the laxative market share of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include Drug Type, Route of Administration, Indication, Distribution, End User and Geography.

For more Lifesciences and Healthcare related reports, please click here

1. Laxatives Market- Market Overview
    1.1  Definitions and Scope
2. Laxatives Market - Executive Summary
    2.1 Market Revenue, Market Size and Key Trends by Company
    2.2 Key trends by drug type
    2.3 Key trends by indication
    2.4 Key trends segmented by geography
3. Laxatives Market – Market Landscape
    3.1  Market Share Analysis
    3.2  Product Benchmarking- Top 5 Companies
    3.3  Financial Analysis - Key Companies
    3.4  Patent Analysis - Key Companies
    3.5  Pricing Analysis
4. Laxatives Market- Market Forces
    4.1 Market Drivers
    4.2 Market Constraints
    4.3 Market Opportunities
    4.4 Porters five force model
        4.4.1 Bargaining power of suppliers
        4.4.2 Bargaining powers of customers
        4.4.3 Threat of new entrants
        4.4.4 Rivalry among existing players
        4.4.5 Threat of substitutes 
5. Laxatives Market – By Drug Type (Market Size -$Million/$Billion)
    5.1  Hyperosmotic
    5.2  Bulk-Forming
    5.3  Stool Softners
    5.4  Lubricants
    5.5  Stimulants
    5.6  Others
6. Laxatives Market  – By Route of Administration (Market Size -$Million/$Billion)
    6.1  Oral 
    6.2  Rectal 
7. Laxatives Market  – By Indication (Market Size -$Million/$Billion)
    7.1  Chronic Constipation
    7.2  Irritable Bowel Syndrome
    7.3  Others
8. Laxatives Market  – By Distribution Channel (Market Size -$Million/$Billion)
    8.1  Hospitals and Clinics
    8.2  Pharmacies
    8.3  Others
9. Laxatives Market  – By End User (Market Size -$Million/$Billion)
    9.1 Children
    9.2 Adults
    9.3 Senior Citizens
10. Laxatives Market -  By Geography (Market Size -$Million/$Billion)
    10.1  North America
        10.1.1 U.S
        10.1.2 Canada
        10.1.3 Mexico
    10.2  Europe
        10.2.1 UK
        10.2.2 Germany
        10.2.3 France
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Rest of Europe
    10.3  Asia-Pacific
        10.3.1 China
        10.3.2 Japan
        10.3.3 South Korea
        10.3.4 India
        10.3.5 Australia & New Zealand
        10.3.6 Rest of APAC
    10.4  Rest of the World
        10.4.1 Middle East
        10.4.2 Africa
        10.4.3 South America
11. Laxatives Market - Entropy
12. Laxatives Market Company Analysis
    12.1 Company Revenue, Products, M&A, Developments
    12.2 Company 1
    12.3 Company 2
    12.4 Company 3
    12.5 Company 4
    12.6 Company 5
    12.7 Company 6
    12.8 Company 7
    12.9 Company 8
    12.10 Company 9
    12.11 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.